Sale!

ABCC8 Gene Diabetes mellitus noninsulin-dependent Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ABCC8 gene plays a crucial role in the regulation of insulin secretion in the pancreas. Mutations in this gene can lead to various forms of diabetes, including non-insulin-dependent diabetes mellitus (NIDDM), also known as Type 2 diabetes. The genetic test for the ABCC8 gene is a valuable diagnostic tool that helps in identifying individuals with a genetic predisposition to this form of diabetes. It is particularly useful for patients with a family history of Type 2 diabetes or those who exhibit potential symptoms of the condition but do not yet meet the criteria for a diabetes diagnosis based on glucose levels alone.

Conducted at DNA Labs UAE, the test involves analyzing the patient’s DNA to look for specific mutations in the ABCC8 gene that are known to affect insulin secretion. This information can be crucial for early intervention and personalized management plans, including lifestyle modifications and targeted therapies that may help in delaying or preventing the onset of Type 2 diabetes.

The cost of the ABCC8 gene diabetes mellitus non-insulin-dependent genetic test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the specialized techniques used for genetic analysis and the expertise required to interpret the results accurately. Patients considering this test are encouraged to discuss it with their healthcare provider to understand its benefits and implications fully.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ABCC8 Gene Diabetes mellitus noninsulin-dependent Genetic Test

Components:

  • Test Name: ABCC8 Gene Diabetes mellitus noninsulin-dependent Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for ABCC8 Gene Diabetes mellitus, noninsulin-dependent NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with Diabetes mellitus, noninsulin-dependent

Test Details:

The ABCC8 gene is associated with a form of diabetes called diabetes mellitus, noninsulin-dependent (NIDDM), also known as type 2 diabetes. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the ABCC8 gene to detect any variations or mutations that may be present. Type 2 diabetes is a chronic condition characterized by high blood sugar levels due to the body’s inability to properly use insulin or produce enough of it. The ABCC8 gene provides instructions for making a protein called sulfonylurea receptor 1 (SUR1), which is involved in the regulation of insulin secretion. NGS genetic testing of the ABCC8 gene can identify specific variations or mutations that may affect the function of the SUR1 protein. These variations can disrupt the normal insulin secretion process, leading to impaired glucose regulation and the development of type 2 diabetes.

Genetic testing for ABCC8 gene mutations can be useful in several ways. It can help diagnose individuals with a genetic predisposition to type 2 diabetes, especially in cases where the cause of the disease is unclear. It can also provide information about the risk of developing diabetes in family members of affected individuals. Additionally, NGS genetic testing can be used to guide treatment decisions. Some ABCC8 gene mutations may respond differently to certain medications used to manage type 2 diabetes, such as sulfonylureas. Knowing the specific genetic profile of an individual can help tailor their treatment plan to optimize their response to medication.

It’s important to note that genetic testing for diabetes is not typically used as a standalone diagnostic tool. It is usually performed in combination with other clinical and laboratory assessments to provide a comprehensive understanding of an individual’s risk and management options for type 2 diabetes.

Test Name ABCC8 Gene Diabetes mellitus noninsulin-dependent Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ABCC8 Gene Diabetes mellitus, noninsulin-dependent NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Diabetes mellitus, noninsulin-dependent
Test Details

The ABCC8 gene is associated with a form of diabetes called diabetes mellitus, noninsulin-dependent (NIDDM), also known as type 2 diabetes. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the ABCC8 gene to detect any variations or mutations that may be present.

Type 2 diabetes is a chronic condition characterized by high blood sugar levels due to the body’s inability to properly use insulin or produce enough of it. The ABCC8 gene provides instructions for making a protein called sulfonylurea receptor 1 (SUR1), which is involved in the regulation of insulin secretion.

NGS genetic testing of the ABCC8 gene can identify specific variations or mutations that may affect the function of the SUR1 protein. These variations can disrupt the normal insulin secretion process, leading to impaired glucose regulation and the development of type 2 diabetes.

Genetic testing for ABCC8 gene mutations can be useful in several ways. It can help diagnose individuals with a genetic predisposition to type 2 diabetes, especially in cases where the cause of the disease is unclear. It can also provide information about the risk of developing diabetes in family members of affected individuals.

Additionally, NGS genetic testing can be used to guide treatment decisions. Some ABCC8 gene mutations may respond differently to certain medications used to manage type 2 diabetes, such as sulfonylureas. Knowing the specific genetic profile of an individual can help tailor their treatment plan to optimize their response to medication.

It’s important to note that genetic testing for diabetes is not typically used as a standalone diagnostic tool. It is usually performed in combination with other clinical and laboratory assessments to provide a comprehensive understanding of an individual’s risk and management options for type 2 diabetes.